- Home
- PSNYW vs JSPR Comparison
PSNYW vs JSPR Comparison
Compare PSNYW & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNYW
- JSPR
- Stock Information
- Founded
- PSNYW N/A
- JSPR 2018
- Country
- PSNYW Sweden
- JSPR United States
- Employees
- PSNYW 2515
- JSPR N/A
- Industry
- PSNYW Auto Manufacturing
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PSNYW Consumer Discretionary
- JSPR Health Care
- Exchange
- PSNYW Nasdaq
- JSPR Nasdaq
- Market Cap
- PSNYW 324.1M
- JSPR 302.0M
- IPO Year
- PSNYW N/A
- JSPR N/A
- Fundamental
- Price
- PSNYW $0.14
- JSPR $22.05
- Analyst Decision
- PSNYW
- JSPR Strong Buy
- Analyst Count
- PSNYW 0
- JSPR 10
- Target Price
- PSNYW N/A
- JSPR $74.86
- AVG Volume (30 Days)
- PSNYW N/A
- JSPR 244.7K
- Earning Date
- PSNYW N/A
- JSPR 11-07-2024
- Dividend Yield
- PSNYW N/A
- JSPR N/A
- EPS Growth
- PSNYW N/A
- JSPR N/A
- EPS
- PSNYW N/A
- JSPR N/A
- Revenue
- PSNYW N/A
- JSPR N/A
- Revenue This Year
- PSNYW N/A
- JSPR N/A
- Revenue Next Year
- PSNYW N/A
- JSPR N/A
- P/E Ratio
- PSNYW N/A
- JSPR N/A
- Revenue Growth
- PSNYW N/A
- JSPR N/A
- 52 Week Low
- PSNYW N/A
- JSPR $4.00
- 52 Week High
- PSNYW N/A
- JSPR $31.01
- Technical
- Relative Strength Index (RSI)
- PSNYW 27.25
- JSPR 54.05
- Support Level
- PSNYW $0.12
- JSPR $19.12
- Resistance Level
- PSNYW $0.24
- JSPR $21.55
- Average True Range (ATR)
- PSNYW 0.02
- JSPR 1.76
- MACD
- PSNYW -0.01
- JSPR -0.25
- Stochastic Oscillator
- PSNYW 11.72
- JSPR 47.64
About PSNYW Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market-leading standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from USA.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.